Vascular stiffness in familial hypercholesterolaemia is associated with C-reactive protein and cholesterol burden

被引:38
|
作者
Cheng, H. M.
Ye, Z. X.
Chiou, K. R.
Lin, S. J.
Charng, M. J.
机构
[1] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei 112, Taiwan
[2] Kaohsiung Vet Gen Hosp, Div Cardiol, Dept Med, Kaohsiung, Taiwan
[3] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan
关键词
arterial stiffness; atherosclerosis; familial hypercholesterolaemia; intima-medial thickness; pulse wave velocity;
D O I
10.1111/j.1365-2362.2007.01772.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Familial hypercholesterolaemia (FH) is characterized by very high serum cholesterol and premature coronary atherosclerosis. Arterial stiffness and atherosclerosis are two major underlying pathophysiologies of arterial disease that are predictive of future cardiovascular events. The aims of this study were to quantify atherosclerosis and arterial stiffness and to evaluate their relationship with high sensitive C-reactive protein (hs-CRP) and the level of exposure to high serum cholesterol in FH patients. Materials and methods We measured traditional risk factors, hs-CRP, intima-media thickness (IMT) of carotid artery, and brachial-ankle pulse wave velocity (baPWV) in 35 heterozygous FH subjects and 17 healthy control subjects. Cholesterol-year score (CYS) was calculated to estimate the lifetime cholesterol burden in FH subjects. Results FH subjects had significantly elevated total cholesterol, low-density lipoprotein cholesterol, and carotid IMT compared with those without mutations. Among FH patients, the baPWV and carotid IMT were higher in cases with high cholesterol burden than those without. Similarly, the baPWV and carotid IMT were also higher in cases with elevated hs-CRP (> 1 mg L-1) than those without. Multiple linear regression analysis demonstrated CYS and hs-CRP were significant independent predictors of baPWV and IMT in FH patients. Conclusions Both high cholesterol burden and vascular inflammation are not only associated with atherosclerosis, but also contribute to the development of arterial stiffness in FH patients. Early detection of hypercholesterolaemia in FH patients is warranted to prevent the untoward pathophysiologies.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 50 条
  • [31] Aliskiren inhibits C-reactive protein driven vascular inflammation
    Hage, Fadi G.
    Szalai, Alexander J.
    Xing, Dongqi
    McCrory, Mark A.
    Chen, Yiu-Fai
    Oparil, Suzanne
    CIRCULATION, 2012, 125 (19) : E709 - E709
  • [32] Genetically elevated C-reactive protein and ischemic vascular disease
    Zacho, Jeppe
    Tybjaerg-Hansen, Anne
    Jensen, Jan Skov
    Grande, Peer
    Sillesen, Henrik
    Nordestgaard, Borge G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18): : 1897 - 1908
  • [33] Clinical implications of C-reactive protein as a predictor of vascular risk
    Katrinchak, Carolyn
    Fritz, Kathryn
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2007, 19 (07): : 335 - 340
  • [34] C-reactive protein (CRP) in cerebro-vascular events
    Canova, CR
    Courtin, C
    Reinhart, WH
    ATHEROSCLEROSIS, 1999, 147 (01) : 49 - 53
  • [35] C-reactive protein and vascular risk: From March to Jupiter
    Di Angelantonio, Emanuele
    Cohen, Ariel
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (03) : 139 - 141
  • [36] C-reactive protein (CRP) as a marker in peripheral vascular disease
    Abdellaoui, A.
    Al-Khaffaf, H.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 34 (01) : 18 - 22
  • [37] C-REACTIVE PROTEIN
    HESS, EV
    MARKHAM, RL
    BRITISH MEDICAL JOURNAL, 1956, 2 (AUG18): : 418 - 418
  • [38] C-REACTIVE PROTEIN
    MUSSER, AW
    JOURNAL OF THE INDIANA STATE MEDICAL ASSOCIATION, 1961, 54 (05): : 644 - &
  • [39] C-REACTIVE PROTEIN
    NUNEZ, EJ
    RIVERO, I
    MEDICINA-BUENOS AIRES, 1980, 40 (04) : 455 - 466
  • [40] C-reactive protein
    Black, S
    Kushner, I
    Samols, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 48487 - 48490